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Introduction
Non-communicable diseases (NCDs) are the leading cause 
of morbidity worldwide. The World Health Organization 
(WHO)1 estimated that 41 million of the 57 million deaths in 
2016 were due to NCDs, the majority of which (78%) 
occurred in low- and middle-income countries (LMICs). The 
prevalence of major NCDs – including cardiovascular dis-
eases (CVDs), cancer, chronic respiratory diseases, and type 
2 diabetes mellitus (T2DM) – is increasing, and they remain 
a challenge for both high-income countries (HICs) and 
LMICs.2–4 Recently, countries in the WHO Western Pacific 
Region (WPR) have seen a drastic increase in NCD mortal-
ity and associated risk factors.5 In addition to an established 
Prevalence of non-communicable diseases 
and their risk factors in Papua New Guinea:  
A systematic review
Patricia Rarau1,2 , Shuaijun Guo1,3 , Shaira Nicole Baptista1,  
Justin Pulford4, Barbara McPake5 and Brian Oldenburg1
Abstract
Introduction: The mortality associated with non-communicable diseases has increased significantly in most countries in 
the World Health Organization Western Pacific Region over the last 20 years, as have the underlying risk factors. This study 
aimed to collate evidence on the prevalence of four major non-communicable diseases and their risk factors in Papua New 
Guinea in order to inform appropriate policy for their prevention and management.
Methods: We performed a systematic review of Papua New Guinea-based population prevalence studies of cardiovascular 
diseases, type 2 diabetes mellitus, chronic respiratory diseases, and cancers, as well as non-communicable disease risk 
factors published before 2016. Five online databases were searched and screened against eligibility criteria according to the 
Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.
Results: A total of 57 articles were included in this review, most of which (n = 48) were published prior to 2000. Eleven 
articles reported on diabetes, six reported on chronic lung disease/asthma, two reported on cardiovascular diseases, and two 
reported cancer as the primary outcome, while the remaining 36 papers reported non-communicable disease risk factors.
Conclusion: This review demonstrated variations in the prevalence of non-communicable diseases (0%–19%) and their 
risk factors (0%–80.6%) attributed to the lifestyle and genetic diversity of the Papua New Guinea population. There is a 
strong suggestion that the prevalence of non-communicable diseases (particularly type 2 diabetes mellitus) and key non-
communicable disease risk factors (hypertension, overweight, and obesity) has increased, but there is a lack of recent data. 
As such, there is an urgent need for new and up-to-date data in all areas of Papua New Guinea.
Keywords
Non-communicable disease, non-communicable disease risk factors, systematic review, Papua New Guinea, population 
studies
Date received: 21 January 2020; accepted: 26 October 2020
1Melbourne School of Population and Global Health, The University of 
Melbourne, Melbourne, VIC, Australia
2PNG Institute of Medical Research, Goroka, Eastern Highlands Province, 
Papua New Guinea
3Centre for Community Child Health, Murdoch Children’s Research 
Institute, Royal Children’s Hospital, Melbourne, VIC, Australia
4Liverpool School of Tropical Medicine, Liverpool, UK
5Melbourne School of Population and Global Health, Nossal Institute for 
Global Health, The University of Melbourne, Melbourne, VIC, Australia
Corresponding author:
Patricia Rarau, Melbourne School of Population and Global Health, The 
University of Melbourne, 333 Exhibition Street, VIC 3010, Australia. 
Emails: prarau@student.unimelb.edu.au; patricia.rarau@gmail.com 
973842 SMO0010.1177/2050312120973842SAGE Open MedicineRarau et al.
research-article2020
Systematic Review
2 SAGE Open Medicine
infectious disease burden,6 the increasing burden of NCDs 
and risk factors pose a grave risk to the future health and 
prosperity of these nations.7
Papua New Guinea (PNG) is an ethnically and linguisti-
cally diverse lower middle-income country in the WPR, with 
a population of 7.3 million people.8 The country has four 
geographical regions: (1) Southern region (SR), (2) Momase 
region (MR), (3) Highland region (HR), and (4) New Guinea 
Islands (NGI) region (Figure 1). PNG has experienced a 
resource boom over the last decade, which has led to 
increased development9 and socio-economic transition.
The PNG WHO statistical profile reported an increase in 
the number of deaths caused by CVDs and T2DM between 
2000 and 2012.10 The limited available evidence in PNG 
suggests a rise in NCDs in recent years, particularly with 
respect to T2DM and CVD. Furthermore, the death estimates 
in the country, as shown by the Global Burden of Disease 
studies, showed that NCD-related deaths – particularly 
ischaemic heart disease, stroke, chronic obstructive pulmo-
nary disease (COPD), and T2DM – increased considerably 
between 2007 and 2017.11 However, prevalence data are 
only available for specific populations, and broader trends 
across the entire population remain unexplored. For exam-
ple, T2DM and pre-diabetes are thought to be especially 
prevalent among the Austronesian language–speaking group, 
comprised of people living in coastal and offshore islands of 
NGI, who are known to carry the thrifty gene;12–14 however, 
it is unclear whether T2DM and its associated risk factors are 
increasing in other ethnic groups. Available hospital-based 
data indicate that coronary artery disease was a rare cause of 
hospital admission in PNG prior to the 1960s.15 Indeed, a 
review of 2000 hospital admissions to the medical ward of 
Port Moresby General Hospital, PNG’s biggest referral hos-
pital, in the 1960s did not reveal a single case of coronary 
heart disease.16 A cancer registry was established in Port 
Moresby in 1958 to register cancer cases across PNG, and 
reviews based on these data indicated a small increase in the 
incidence of cancer between 1958 and 1988.17,18 However, it 
is unknown whether the registry still exists, is regularly 
updated, or whether any further review has been performed. 
Available but limited data on chronic respiratory diseases 
also indicate that chronic lung disease (CLD) is prevalent in 
both the highland and coastal areas of the country.19 However, 
it is unknown whether there has been any increase or decrease 
in the prevalence in the general population.
Although some small studies have found relevant evi-
dence from particular communities, to date, there has been no 
attempt to perform a systematic and comprehensive review of 
all available NCD data. Available prevalence data from PNG 
are limited and inconsistent, and thus needs to be synthesised. 
Therefore, this study aimed to collate evidence on the preva-
lence of four major NCDs, namely, CVD, T2DM, chronic 
respiratory diseases, and cancers, and their associated risk 
factors, in order to establish the extent of available evidence. 
Findings from this study can be used to inform policy con-
cerning the prevention and control of NCDs in PNG.
Figure 1. Map of Papua New Guinea.
 : Port Moresby, capital city.
Source: https://d-maps.com/pays.php?num_pay=286&lang=en.
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Methods
Based on the protocol (Supplemental Appendix 1), a system-
atic review was undertaken of PNG-based, general popula-
tion prevalence studies for selected NCDs (coronary heart 
diseases and stroke, T2DM, CLD/COPD/asthma, and can-
cers of the breast, lungs, stomach, liver, and oral), and their 
risk factors published before 2015.
Search strategy
The review was conducted in accordance with the Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses 
(PRISMA) guidelines.20 An initial (September 2015) and 
updated (July 2016) electronic search was undertaken using 
the following five databases: PubMed, MEDLINE, Scopus, 
Web of Science, Centre for Agriculture and Biosciences 
(CAB) abstracts, and Global Health. The following key terms 
were employed: ‘Papua New Guinea’ AND ‘non-communi-
cable disease’ OR cardiovascular disease. A full list of the key 
search terms is available in the appendix (Supplemental 
Appendix 2). Additional articles were sought by a manual 
review of the listed references in the retrieved articles.
Inclusion/exclusion criteria
This review was limited to published peer-reviewed papers 
in English. For an article to be included, the following crite-
ria had to be met in accordance with the PICOS (population, 
intervention, comparator, outcome, and study design) princi-
ple in the Cochrane Handbook:21
1. Participants: general Papua New Guinean adult pop-
ulation (15+ years).
2. Outcomes: prevalence data relating to one or more of 
the following NCDs:
(a) T2DM.
(b) CVDs, particularly coronary heart disease and 
stroke.
(c) COPD and asthma.
(d) Cancers of the mouth, lungs, liver, stomach, and 
breast.
3. And/or prevalence data of associated risk factors lim-
ited to:
(a) Hypertension.
(b) Elevated lipids.
(c) Overweight and obesity.
(d) Lack of physical activity.
(e) Tobacco smoking.
(f) Harmful use of alcohol.
4. Study design: population-based studies that pre-
sented the prevalence of NCDs and their risk 
factors.
Articles were excluded if:
5. They did not meet the inclusion criteria.
6. The full-text article was not available.
7. The sample size was less than 100.
Data extraction and study selection
As shown in Figure 2, a total of 5039 records were imported 
into EndNote X7 (EndNoteTM); from this, 4117 duplicates 
were removed, and the remaining 922 article titles and 
abstracts were independently screened by two authors, P.R. 
and S.G. Based on the abstract and title review, 719 studies 
were excluded. The full texts of the remaining 203 studies 
were separately reviewed by P.R. and S.G. using the inclu-
sion and exclusion criteria, with discrepancies resolved by 
consensus opinion. A total of 154 articles were excluded fol-
lowing full-text review, leaving 49 relevant articles. A man-
ual search of the references listed in these included articles 
yielded another eight articles which met the inclusion crite-
ria. The data reported in 57 articles were independently 
extracted by P.R., S.G., and S.N.B., with discrepancies 
resolved by consensus opinion.
Data extracted from these articles were based on the 
Cochrane Handbook for Systematic Reviews,21 and included 
author(s), study aim(s), methodology, population surveyed, 
and the primary outcome or prevalence data.
Quality assessment of the included 
studies
The quality of the included studies was reviewed by P.R., 
S.G., and S.N.B, using an adapted version of the Joanna 
Briggs Institute (JBI) Critical Appraisal tools for Systematic 
Reviews;22 the adapted version of the appraisal tool is a 
merged checklist for prevalence and cross-sectional studies 
(see Supplemental Appendix 3). Using the JBI checklist, P.R., 
S.G., and S.N.B. independently appraised each article and 
tabulated the combined quality assessment, any disagreement 
was resolved through discussion. The checklist focused on 12 
areas, which each published study was measured against; this 
included the use of an appropriate sampling frame, appropri-
ate sampling of participants, adequate sample size, descrip-
tion of the study setting and subjects, eligibility criteria 
clearly defined, valid and reliable measure of exposure, valid 
methods used to define conditions, data analysis, appropriate 
statistical analysis used, identifying and dealing with con-
founding factors, and adequate response rates.
Data synthesis
A narrative synthesis was conducted by P.R. under the four 
major disease headings of T2DM, CLD, CVD, cancer, and 
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risk factors. It was not possible to calculate the pooled preva-
lence of the diseases and risk factors due to the high variabil-
ity among the studies.
Results
Description of the included studies
A total of 57 articles fulfilled the inclusion criteria. Eleven 
articles23–33 reported on T2DM as the primary outcome, six 
articles reported on CLD/asthma,34–39 two articles reported 
on CVDs,40,41 and two reported on cancer42,43 (Supplemental 
Table S1). The remaining 36 articles reported the prevalence 
of NCD risk factors as the primary outcome, including 
hypertension (n = 9),44–52 lipids (n = 6),53–58 overweight and 
obesity (n = 3),59–61 tobacco smoking (n = 1),62 and a combi-
nation of risk factors (n = 17)63–79 as shown in Supplemental 
Table S2. The largest proportion of surveyed regions in the 
published studies were the Southern (n = 21) and Highland 
(n = 16) regions of PNG (Table 1).
Quality assessment
Using the JBI critical appraisal checklist for cross-sectional 
and prevalence studies, 20 studies checked ⩾80% of the 
items on the checklist. The majority (49%) of the studies 
rated between 60% and 80%, and none of the papers rated 
below 50%; thus, no studies were excluded as a result of 
poor quality. The strengths included the validity of the expo-
sure measurement and appropriate description of the subject/
site (see Supplemental Appendix 4).
NCDs and risk factors
Prevalence of T2DM. As shown in Supplemental Table S1, 
the prevalence of T2DM ranged from 0% in studies among 
civil servants residing in Port Moresby26 and a population 
from Goroka, Eastern Highland Province (EHP) in the 
1980s29 to 20.4% among Port Moresby residents in 2001.33 
Seven studies defined T2DM as a condition characterised by 
hyperglycaemia as per WHO diagnostic criteria: fasting 
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Figure 2. Flow diagram showing the articles screened and considered for inclusion in this review.
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Table 1. Summary of the characteristics of the included articles..
Number Author Study design, response rate, 
target age group, gender
Target population, province, 
region
Type of NCD 
or risk factor as 
primary outcome  
of interest reported
Adult 
participants 
(total)
Diabetes mellitus
1 Benjamin33 Cross-sectional study, NR,  
12+, males and females
Port Moresby residents,  
NCD, Southern region
Diabetes mellitus 
type 2
235
2 Lindeberg et al.32 Cross-sectional study, 42%, 
20+, males and females
Kitava Island, Milne Bay 
Province, Southern region
Blood insulin and 
glucose
170
3 Dowse et al.31 NR, 73.7%, 25+, males and 
females
Koki, Port Moresby,  
Wanigela and Kalo, Central 
Province, Southern region
Diabetes mellitus 1402
4 King et al.30 Cross-sectional study, 91%, 
60%, 78%, 20+, males and 
females
Gamog, Marup and Kaul,  
Madang Province. Momase 
region
Diabetes mellitus 
type 2
637
5 King et al.29 Community survey, >87%, 
adults, males and females
Asaro, EHP and Matupit, 
Napapar in East New Britain 
Province. Highlands and New 
Guinea Islands region
Diabetes mellitus 
type 2
799
6 Patel et al.28 Community survey, >34%,  
18+, males and females
Wanigela, Central Province. 
Southern region
Diabetes mellitus 
type 2
192
7 King et al.27 Prospective study, 95%,  
20+, males and females
Asaro, EHP. Highlands  
Region
Diabetes mellitus 
type 2
324
8 Martin et al.26 Cross-sectional study, NR,  
18+, males and females
Civil servants, Port Moresby, 
NCD. Southern region
Diabetes mellitus 
type 2
118
9 Martin et al.25 Community survey, 28%  
rural, 30% urban, 18%,  
males and females
Rural Kalo, Central  
Province, urban Koki, Port 
Moresby, NCD. Southern  
region
Diabetes mellitus 
type 2
290
10 Price and Tulloch24 Household survey, >88%,  
20+, males and females
Port Moresby, NCD.  
Southern region
Diabetes mellitus 
type 2
3313
11 Hingston and Price23 Community survey, NR,  
20+, males and females
Hula, Central Province,  
Port Moresby, NCD.  
Southern Region
Diabetes mellitus 1464
Chronic lung disease/asthma
12 Woolcock et al.39 Cross-sectional study,  
NR, 20+, males and  
females
Asaro Valley, EHP,  
Highlands region
Asthma and  
chronic airflow 
limitation
743
13 Dowse et al.38 NR, NR, 20+, males and 
females
Goroka, EHP, Highlands  
Region
Asthma 404
14 Woolcock et al.37 Cross-sectional, NR, 20+,  
males and females
South Fore, EHP.  
Highlands region
Asthma 1817
15 Anderson36 Cross-sectional study, 95%, 
15+, males and females
Lufa, EHP, Highlands  
region
Asthma,  
respiratory 
abnormalities, lung 
function defect, and 
smoking habits
1284
16 Anderson35 Community study, NR,  
adults, males and females
Lufa, EHP, Highlands  
region
Asthma 122
17 Woolcock and 
Blackburn34
Epidemiology and  
longitudinal study, NR, 20+, 
males and females
Enga and Chimbu natives,  
Enga and Chimbu Province, 
Highlands region
Chronic lung  
disease
717
Cardiovascular disease
18 Lindeberg and  
Lundh41
Cross-sectional study, 63% 
(>50 years), 45% (<50 years), 
20+, males and females
Kitava Island, Milne Bay 
Province, Southern region
Stroke and 
ischaemic heart 
disease
213 but ECG 
on 171
19 Sinnett and  
Whyte40
Cross-sectional, 95%, 15+, 
males and females
Murapin, Enga Province. 
Highlands region
Cardiovascular 
disease
779
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Number Author Study design, response rate, 
target age group, gender
Target population, province, 
region
Type of NCD 
or risk factor as 
primary outcome  
of interest reported
Adult 
participants 
(total)
Cancer
20 Thomas et al.43 Cross-sectional study, 74%, 
18+, males and females
Kavieng, New Ireland  
Province, New Guinea  
Islands region
Leukoplakia, 
smoking, and 
chewing betel nut
1678
21 Pindborg et al.42 NR, NR, 20+, males and 
females
Central, Madang and  
Western Highlands Provinces. 
Southern, Momase and 
Highlands regions
Leukoplakia, 
smoking, and 
chewing betel nut
1226
Hypertension
22 Benjamin52 Cross-sectional study, NR,  
20+, males and females
Koki, Mt. Obree, Balopa,  
Upper Strickland river.  
National Capital District, 
Central, Manus and Southern 
Highlands. Southern, NGI and 
Highlands region
Hypertension 1491
23 Ulijaszek51 Cross-sectional, NR, 18+,  
males and females
Baroi and Purari Delta, Gulf 
Province. Southern region
Hypertension 103
24 Schall50 NR, NR, adults, males and 
females
Pere, Manus Province, New 
Guinea Islands region
Hypertension 173
25 King et al.49 Cross-sectional study, 85%  
and 78% and 60% for Karkar 
only, NR for Tolai and 
Masilkaiufa, 20+, males and 
females
Karkar Island, Matupit and 
Napapar, Masilkaiufa. Madang, 
East New Britain Province,  
EHP. Momase, NGI and 
Highlands regions
Hypertension and 
other CVD risk 
factors
1455
26 Carvalho et al.48 Community study, NR, 20+, 
males and females
Kamus and Gimisave, EHP, 
Highlands region
Blood pressure 162
27 King et al.47 Cross-sectional study, 95%, 
20+, males and females
Asaro Valley, EHP, Highlands 
region
Hypertension 308
28 Maddocks46 Community study, NR, 15+, 
males and females
Chimbu, Kapuna in Gulf, 
Hanuabada in NCD, mainland 
PNG. Highlands, Momase, 
Southern regions
Blood pressure 
anthropometry
2155
29 Maddocks and  
Vines45
Community survey, NR, 20+, 
males and females
New Guinea mainland,  
Momase, Highlands and 
Southern regions
Blood pressure, 
spleen, and lung 
function
238
30 Maddocks and  
Rovin44
Community survey, NR, 20+, 
males and females
Mintina, Wandi Gumine,  
Chimbu Province, Highlands 
region
Blood pressure 429
Lipids
31 Lindeberg et al.58 Cross-sectional study, NR,  
20+, males and females
Kitava Island, Milne Bay 
Province, Southern region
Lipids, body mass 
index, blood 
pressure
169
32 Lindeberg et al.57 Cross-sectional study, NR,  
20+, males and females
Kitava Island, Milne Bay 
Province, Southern region
Lipids 151
33 Hodge et al.56 Cross-sectional study, 46%–
88%, 25+, males and females
Koki, Kalo and Wanigela,  
Asaro Valley. NCD, Central  
and EHP. Southern and 
Highlands regions
Lipids, overweight, 
and diabetes 
mellitus type 2
1875
34 Iser and Avera55 Cross-sectional study, NR,  
18+, males and females
Bougainville, Autonomous  
Region of Bougainville, NGI 
region
Lipids and obesity 150
35 Erasmus et al.54 Cross-sectional study, 100%, 
18+, males and females
Port Moresby, NCD,  
Southern region
Lipids and obesity 148
36 Wyatt et al.53 Community study, 17%–20%, 
18+, males and females
Kalo in Central Province,  
Koki in NCD. Southern region
Lipids 180
Table 1. (Continued)
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Number Author Study design, response rate, 
target age group, gender
Target population, province, 
region
Type of NCD 
or risk factor as 
primary outcome  
of interest reported
Adult 
participants 
(total)
Overweight/obesity
37 Benjamin61 Community survey, 88.2% 
anthropometry, 80% for blood 
sampling, 20+, males and 
females
Koki, Mt Obree, Balopa,  
Upper Strickland. NCD,  
Central, Manus and Southern 
Highlands Province. Southern, 
NGI and Highlands
Overweight/obesity 1491
38 Ulijaszek60 NR, NR, 20+, males and 
females
Purari Delta, Gulf Province. 
Southern region
Overweight and 
obesity
270
39 Norgan59 Community survey, NR,  
20+, males and females
Karkar Island, Madang  
Province and Lufa, EHP,  
Momase and Highlands region
Modernization, 
anthropometry, 
overweight
1094
Tobacco smoking
40 Vallance et al.62 Community survey, 96%,  
15+, males and females
Lufa, Eastern Highlands 
Province, Highlands region
Tobacco smoking 544
Combined NCD risk factors
41 Yamauchi79 NR, NR, 20+, males and 
females
Huli, Hela Province,  
Highlands region
Physical 
activity levels, 
anthropometry, 
body fat
253
42 Kende78 Cross-sectional study, NR,  
25+, males and females
Tari and Port Moresby,  
Hela and NCD. Highlands  
and Southern region
Obesity and lipids 221
43 Natsuhara et al.77 NR, NR, 20+, males and 
females
Huli and Balopa migrants  
in Port Moresby, NCD, 
Southern region
Hypertension,  
lipids, obesity, 
smoking, alcohol
173
44 Lindeberg et al.76 Cross-sectional study, 42%, 
20+, males and females
Kitava Island, Milne Bay 
Province, Southern region
Blood pressure, 
lipids, body mass 
index, tobacco 
smoking
203 
anthropometry, 
162 for blood 
sample
45 Hodge et al.75 Cross-sectional study, 77%, 
25+, males and females
Wanigela, Central Province, 
Southern region
Microalbuminuria, 
cardiovascular 
factors and insulin 
resistance, DM
359
46 Hodge et al.74 Cross-sectional study, NR,  
25+, males and females
Koki, NCD. Southern region Hypertension, 
obesity, lipids and 
diabetes mellitus 
type 2
285
47 Hodge et al.73 Cross-sectional study, 46%–
88%, 25+, males and females
Koki, Kalo and Wanigela,  
Asaro valley. NCD, Central  
and EHP. Southern and 
Highlands regions
Modernity and 
obesity
1875
48 Lindeberg et al.72 Cross-sectional study, 59% 
(>50 years) 40% (<50 years), 
14–87
Kitava Island, Milne Bay 
Province, Southern region
Lipids, blood 
pressure, body  
mass index,  
skinfold thickness, 
smoking
270 for 
anthropometry, 
180 for blood 
sample
49 Scrimgeour et al.71 Cross-sectional study, NR,  
17+, males and females
Asaro, EHP, Highlands  
region
Lipids, diabetes 
mellitus type 2, 
smoking
121
50 Date et al.70 Community study, 79%–88%, 
15+, males and females
Beha District, EHP, Highlands 
region
Anthropometry  
and blood analysis
440
51 Inaoka et al.69 Community study, NR,  
20+, males and females
Gidra, Western Province. 
Southern region
Blood pressure  
and body mass 
index, urinary 
sodium
250
Table 1. (Continued)
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Number Author Study design, response rate, 
target age group, gender
Target population, province, 
region
Type of NCD 
or risk factor as 
primary outcome  
of interest reported
Adult 
participants 
(total)
52 Boyce et al.68 NR, NR, 21+, males and 
females
Karkar Island, Madang  
Province, Momase region
Blood pressure, 
body mass index, 
lipids
440
53 Hornabrook et al.67 Community study, NR,  
15+, males and females
Karkar Island, Madang  
Province, Lufa in EHP,  
Momase and Highlands  
regions
Socioeconomic 
status, 
anthropometry, 
blood pressure,  
and cholesterol
1982
54 Hornabrook et al.66 Community study, NR, all  
ages, males and females
Karkar Island in Madang 
province, Lufa in EHP.  
Momase and Highland regions
Anthropometry, 
blood pressure, 
biochemical 
parameters
3700, unable 
to disaggregate 
adults from 
general 
population
55 Barnes65 Community study, NR, adults, 
males and females
Lower Bomai, Yongamuggi, 
Chimbu Province. Highlands 
region
Anthropometry, 
blood pressure,  
and lipids
488
56 Whyte64 Cross-sectional, NR, 20+,  
males and females
Chimbu and Gulf Provinces. 
Highlands and Southern  
region
Blood pressure  
and body fat
531
57 De Wolfe and 
Whyte63
NR, NR, 20+, males and 
females
Wabag, Enga Province,  
Chimbu Province, Gulf  
Province, Highlands and 
Southern region
Total cholesterol 
and lipoprotein, 
obesity
242
NCD: National Capital District; EHP: Eastern Highland Province; NR: Not reported; ECG: electrocardiogram; NGI: New Guinea Islands; CVD: cardio-
vascular disease; PNG: Papua New Guinea; DM: diabetes mellitus.
Table 1. (Continued)
plasma glucose (FPG) >7 mmol/L, 2-h oral glucose (75 g) 
tolerance test (OGTT) ⩾11 mmol/L, or use of anti-diabetic 
drugs.25–31 Of the remaining four studies, one diagnosed dia-
betes using fasting capillary blood glucose (⩾7.0 mmol/L);33 
two screened urine for glycosuria,23,24 and applied the OGTT 
to confirm diabetes among those with glycosuria; and one 
reported the mean glucose and insulin levels in the studied 
population.32
Prevalence of asthma and CLD. The prevalence of asthma 
ranged from 0.2%, in a population from Goroka in 197235 to 
7.3% among the South Fore (EHP) population in 1980.37 
Furthermore, the prevalence of CLD was 11% among a com-
bined general rural population from Enga and Western High-
land Province (WHP) in 1967.34 Five studies reported on 
asthma, while two reported CLD as the main outcome. 
Asthma and CLD were diagnosed through combined investi-
gations, including clinical history, lung function test, and 
histamine inhalation test (HIT).
Prevalence of CVD. Only two studies have reported on the 
prevalence of coronary heart disease; one was conducted in 
the Enga Province in the Highland region in 1966,40 and the 
other was from Kitava Island in Milne Bay Province in the 
southern region in 1990.41 The former study reported a 6.9% 
prevalence of coronary heart disease based on history of 
angina and claudication, and was supported by relevant clin-
ical electrocardiographic (ECG), radiological, and biochem-
ical findings. Abnormalities suggestive of heart disease (8%) 
were found by ECG among the Kitava population; however, 
this was considered inconclusive for coronary heart disease.
Prevalence of cancer. Only two published articles have 
reported on the prevalence of leukoplakia,42,43 a premalig-
nant lesion of the oral mucosa, based on history and oral 
mucosa examination. The former study was conducted 
between 1958 and 1963 in two coastal villages and one high-
land province. The reported overall prevalence of leukopla-
kia was 4.6% among the population of the coastal 
communities, and reported a higher prevalence compared to 
the highland community.42 The latter study was conducted in 
1992 in a coastal community in New Ireland Province.43 The 
overall prevalence of leukoplakia was reported as 11.7%. 
Similar to the previous study, a high prevalence of leukopla-
kia coincided with a high prevalence of betel nut chewing.
Prevalence of individual NCD risk factors. As shown in Sup-
plemental Table S2, 36 studies reported the prevalence of 
one or more NCD risk factors as the primary outcome; these 
risk factors included hypertension, dyslipidaemia, alcohol 
consumption, overweight and obesity, betel nut chewing and 
tobacco smoking, and a diet high in fat and salt.
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Hypertension. Nine studies reported high blood pressure as 
the primary outcome.44–52 However, only six reported the 
prevalence of hypertension, which was defined as blood 
pressure ⩾140/90 mm Hg in five studies48–52 and 
⩾160/95 mm Hg in one study; the remaining three studies 
only reported the mean blood pressure. The prevalence of 
hypertension was reported to be as high as 19.7% in a coun-
trywide study conducted between 1996 and 2000,52 and as 
low as 0.8% in an Asaro population in the EHPs in 1989.48
Dyslipidaemia. Six studies reported on lipids as the primary 
outcome. Of these, only three articles reported the preva-
lence of high cholesterol levels, two of which also reported 
high triglyceride levels, while the remaining three only pre-
sented the mean levels.53,57,58 The prevalence of high choles-
terol and triglyceride levels was as high as 26% and 11.9%, 
respectively, in a study of National Capital District (NCD) 
residents, and as low as 8% and 6.9%, respectively, in a 
combined EHP and central study population. For studies 
that reported high cholesterol levels, two studies54,56 used 
5.2 mmol/L, and one study used 5.5 mmol/L as cut-off 
levels.55
Overweight and obesity. The prevalence of overweight ranged 
from 4.8% in a study of rural populations from Karkar Island, 
Madang (MR) and Lufa, and EHP (HR) in the 1990s59 to 
28.4% in 2007 in a combined population from Port Moresby 
(SR), Central (SR), Southern Highlands Province (HR), and 
Manus (NGI).61 Three studies measured and reported the 
prevalence of overweight and obesity as the main outcome. 
In two studies, overweight and obesity were defined as a 
body mass index (BMI) ⩾25 and ⩾30 kg/m2, respec-
tively,60,61 while the third study defined obesity as a BMI 
⩾25 kg/m2.59 The prevalence of obesity (14.1%) and over-
weight (28.4%) was the highest in a study on a combined 
group of people from Port Moresby, Manus, Central, and 
SHP, that was conducted between 1999 and 2002.61
Tobacco smoking. Only one study reported tobacco smoking 
as the primary outcome;62 this was a study in the Eastern 
Highlands, which reported the prevalence of tobacco smok-
ing among an adult population. The overall prevalence of 
tobacco smoking was 52.9% and was the highest among 
males compared to females.
Studies that reported multiple NCD risk factors. Seventeen 
studies, as shown in Supplemental Table S2, reported on 
multiple risk factors, including adiposity, obesity, hyperten-
sion, high lipids, high glucose and microalbuminuria, 
tobacco smoking, alcohol consumption, and salt consump-
tion. Of the three studies64,69,79 that reported on adiposity, 
two presented the prevalence, while the third reported the 
mean. The highest prevalence of body fatness (21.5%) was 
reported in a study conducted among a group of Tari people 
(SHP, Highlands) between 1994 and 1995.79
BMI was measured in 14 studies,63,66–70,72–79 but the prev-
alence of obesity (⩾30 kg/m2) was reported in only six. The 
overall obesity prevalence ranged from 38.6% in a study 
conducted in 1991 among the Koki people living in Port 
Moresby,74 which was absent in a study of Chimbu (HR) 
people in the 1950s.63
Blood pressure was measured in 13 studies;63–70,72,74–77 
however, the prevalence of hypertension was reported in 
only four articles, of which, three define hypertension as 
>140/90 mm Hg. The reported prevalence ranged from 
16.8% among the Koki people of Port Moresby in 199174 to 
0.4% in a study of people from Chimbu in 1965.65
Only one study has reported on the prevalence of micro-
albuminuria75 in an urban population. Microalbuminuria was 
defined as 20–200 µg/mL, and the prevalence of microalbu-
minuria among the urban population of Koki in Port Moresby 
was 40.5%.
Lipid levels were measured in 13 studies,63,65–68,70–72,74–78 
although only five reported on the prevalence of high choles-
terol.63,65,71,77,78 The prevalence of high cholesterol levels 
ranged from 17% in a study conducted in 1997 among Tari 
people78 to complete absence in three studies conducted in 
the 1950s–1960s in Chimbu Province and EHP in 1988.63,65,71 
Only one study77 reported the prevalence of low high-density 
lipoprotein cholesterol (HDL-c) (47.4%) and high lipopro-
tein A (21.4%); this study was conducted in 1995 on a group 
of people living in Port Moresby, who migrated from Tari in 
Hela Province and Balopa in Manus Province.
The prevalence of tobacco smoking was reported in four 
studies,67,71,76,77 with two reporting daily use of tobacco.71,76 
The overall prevalence was reported to be as high as 77% in 
a study conducted in 1990 among the Kitava people of the 
Milne Bay Province.
Alcohol use was reported in two studies,67,77 neither of 
which specified how this was measured, with the highest 
prevalence of 42% from the study conducted in 1995 in Port 
Moresby.77 There were only two studies that measured salt 
consumption but did not present any prevalence data.65,69
Discussion
This systematic review reports on published studies that 
were conducted in PNG between 1950 and 2007. It is diffi-
cult to draw conclusions about the prevalence and risk fac-
tors of NCDs because of the limited amount of data, disparate 
ethnic groups, and the fact that the majority of studies were 
not recent. However, our findings suggest an increase in 
NCD prevalence across PNG, particularly in relation to 
T2DM and risk factors such as hypertension, overweight, 
and obesity, but there remains a lack of recent data. 
Importantly, the findings further suggest that populations 
with longer and greater exposure to modernisation, such as 
those living in urban areas, those with increasing and easy 
access to pre-packaged food (as opposed to traditional local 
food), and those with a genetic predisposition tended to have 
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a higher prevalence of CVD risk factors. Most studies were 
conducted over two decades ago, most likely due to the lim-
ited attention given to NCDs and the lack of funding and 
capacity to conduct studies on a regular basis.
The majority (n = 9) of the studies on T2DM were con-
ducted in the Southern region, specifically in the Central 
Province and Port Moresby. Populations living in these two 
provinces have had longer exposure to modernisation than 
most other regions of PNG. In addition to lifestyle changes, 
there is evidence to show that the Motuans, who are of 
Austronesian ancestry, in the Central Province have a genetic 
predisposition to T2DM.29,31 Hence, it is not surprising to 
find a higher prevalence of T2DM in urban or peri-urban 
communities, such as Koki in Port Moresby, compared to 
villages in rural Central Province.
In urban settings, it is evident that an increasing propor-
tion of the diet consists of high-energy processed food pur-
chased from shops, whereas garden produce is being 
consumed less. As reported in the 2007/2008 PNG STEPS 
survey, the majority of the surveyed population consumed 
less than the recommended daily servings of fruit and vege-
tables.80 Furthermore, adults living in cities and urbanised 
areas are more likely to be engaged in sedentary employment 
compared to the more strenuous subsistence farming and 
gardening that are common in rural areas.25,31,81 This was 
evident in the study by Kende, who reported a significantly 
higher prevalence of CVD risk factors among a group of 
people living in Port Moresby who originated from the rural 
highlands. It was reported that those who migrated to the city 
to live were less active, had a higher mean body weight, 
lipids, and glucose compared to their rural counterparts who 
were still living in the village.78
Our review only found two studies that reporting the 
prevalence of CVD in the general population, both of which 
were conducted over two decades ago. Considering the high 
prevalence of CVD risk factors reported here, and the growth 
of PNG’s economy over the past decade,82 the current burden 
of CVD is likely to be substantially higher than that indi-
cated in these dated publications.
All studies on CLD/asthma were conducted in the 
Highlands region, the majority of which were in the EHP at 
the headquarters of the country’s national research institute. 
The EHP is located at an altitude of 1500 m above sea level, 
with warm weather during the day and often cold nights. 
Village people living in traditional huts would usually have a 
wood fire going to keep the hut warm at night. Respiratory 
infections are the leading cause of admission and death in the 
highlands provinces due to early childhood bacterial infec-
tion, cold weather, and other environmental factors, such as 
high exposure to air pollution from wood smoke.83,84 In addi-
tion, the prevalence of asthma showed an upward trend 
among a rural population within the same province, but was 
lower in the urban population,38 with an age of onset in adult-
hood. Environmental factors, in particular house dust mites, 
were among the precipitating factors in most of the cases,35,37,38 
which is consistent with previous reviews of causative agents 
for asthma.85,86
Our review found only two studies that reported on the 
prevalence of leukoplakia, a premalignant cancer in the gen-
eral community. One was conducted more than 50 years ago 
in one highland and two coastal populations, while the other 
was conducted in 1992 on an island population. The preva-
lence of leukoplakia was higher among the island population 
than in the other study. The lack of research on premalignant 
cancer is of great concern given the high rates of known risk 
factors, such as betel nut use and tobacco smoking, across 
the country,58,62,80,87 as both are associated with oral can-
cer.88–90 A review of the cancer registry published in 1992 
showed an increasing incidence of oral carcinoma;17 how-
ever, to date, no study has provided an updated cancer preva-
lence in the general community.
The prevalence of hypertension ranged from 0 in the 
1960s, from rural populations with limited contact with 
modernisation, to 30.9% and 24.7% in the early 2000s, 
among rural Manus and urban Port Moresby populations, 
respectively. The high prevalence does not necessarily reflect 
widespread increase in hypertension, as both Port Moresby 
and Manus have had long-term exposure to Western influ-
ence; therefore, baseline and follow-up data may not be com-
parable, even though rural Manus has been exposed to 
Western-type diet since the 19th century as a consequence of 
the settlement of European missionaries and Germans. This 
is consistent with another study from the Purari Delta in the 
Gulf Province, which reported increased blood pressure and 
BMI with increasing modernisation.51 Consistent with the 
increasing prevalence over the years, the 2007/2008 PNG 
STEPS survey reported a hypertension prevalence of 8.8% 
among the population survey.80 Furthermore, a review on 
hypertension in LMICs, as well as in a neighbouring Pacific 
island, showed an increased prevalence of hypertension in 
urban populations compared to their rural counterparts.91–93
The prevalence of overweight and obesity was mainly 
reported in studies from the Momase and Southern regions. 
The lowest prevalence was observed in rural communities in 
Madang and EHP, which showed a minimal increase over the 
years,59 while the prevalence was the highest in peri-urban and 
urban areas in PNG.55,74,78 However, the 2007/2008 PNG 
STEPS survey, which was conducted in four different prov-
inces and the NCD, reported a considerably higher prevalence 
of overweight and obesity; indeed, it was found that 32% of 
the survey participants have a BMI of ⩾25 kg/m2.80
Although not widely reported, the high prevalence of 
tobacco smoking is consistent with the results of the PNG 
STEPS survey,80 as well as a recent survey94 completed after 
the review period, which also showed a very high prevalence 
of tobacco smoking in certain PNG populations. Given that a 
high prevalence has been documented over time, it is quite 
possible that PNG is already experiencing a substantial 
health burden because of smoking; however, its true extent 
has not yet been documented.
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Similarly, alcohol use was not widely reported in the 
reviewed publications and was poorly defined when it was. 
The data that were available suggest that alcohol consump-
tion is the lowest in remote or rural populations.67,77 Globally, 
there is evidence showing an increased risk of cancers, liver 
disease, and CVDs with the harmful use of alcohol.95 In 
PNG, few people can afford to regularly consume high quan-
tities of commercially produced alcohol; therefore, its use is 
highest among people living in towns or urban areas with 
paid employment. In PNG, the health risk more likely to be 
associated with alcohol use is accidents and injury, as out-
lined in previous studies, rather than effects of long-term 
over consumption.96,97
Betel nut chewing is relatively understudied given its 
level of use and cultural importance in PNG. Although it was 
not a primary outcome, the prevalence of betel nut chewing 
reported in one of these studies was very high, particularly 
from a specific population from the coastal area of PNG,42 
which is consistent with a more recent study.94 Similarly, the 
PNG STEPS survey also reported that chewing betel nut was 
highly prevalent among the surveyed participants from four 
different provinces across PNG and the city of Port Moresby. 
Associations with oral cancer, and other health-related risks, 
as seen in other countries98–101 are a serious concern in PNG 
that warrants further investigation.
Strengths and limitations
This is the first paper to review articles that have reported on 
the prevalence of NCDs and their risk factors in PNG. In 
addition, the findings are based on a methodological quality 
assessment that ensures a relatively robust evidence base. 
Various methods are used for data collection and for ascer-
taining NCDs and their risk factors, which makes it difficult 
to compare results between these studies. This review was 
limited to cross-sectional published articles, and therefore 
would have missed papers reporting on NCD and risk factor 
prevalence in the grey literature, as well as in other types of 
studies, such as cohort/case-control and randomised control 
studies. In addition, some risk factor–related work may have 
been missed or fallen outside of our search terms, and there-
fore would not have been included in this review. Furthermore, 
some of these studies had limited information and/or only 
reported the mean measurements. Moreover, the small num-
ber of studies with a lack of recent data, in addition to the 
limited information provided in some of the articles, made it 
difficult to determine the prevalence or mean trends. The 
studies were conducted in very diverse ethnic groups; there-
fore, it is impossible to draw conclusions from the general 
population of PNG. Attempts to follow up on further infor-
mation proved to be difficult with no current contact details.
Research and policy implications
As indicated by this review, NCD risk factors are not evenly 
distributed across PNG or across time. Thus, trends across 
time and between populations cannot be reliably identified 
based on the currently available information. However, con-
sidering the above limitations, available evidence suggests 
that NCD risk factors are not evenly distributed and have 
increased over time. The uneven distribution is not only due 
to the diverse lifestyle of the population but also their genetic 
diversity. Indeed, as indicated previously, the high preva-
lence of NCD risk factors among peri-urban and urban popu-
lations, as well as within some populations, is further 
enhanced by the genetic predisposition, especially in popula-
tions with Austronesian ancestry.
It is obvious that there is a need for a structured NCD risk 
factor surveillance and better data, with systematic monitor-
ing across all provinces. Therefore, it is suggested that rou-
tine screening for NCDs and their risk factors be integrated 
into existing healthcare services to enable early detection of 
high-risk individuals. This will also ensure the consistency 
of measurement and criteria to identify these conditions, 
such that combined prevalence data may be obtained for the 
country.
PNG conducted its first WHO STEPS NCD risk factor 
survey in 2007/2008.80 The survey was conducted in four 
provinces across PNG and the NCD. However, even though 
the survey achieved a response rate of 80%, it was from a 
non-randomised sample, and unfortunately, the survey has 
not been repeated since.
Updated NCD risk factor prevalence data from all provinces 
across the country will aid policymakers in planning NCD pre-
vention and control strategies in PNG. Considering the geo-
graphical difficulties and remoteness of communities in rural 
areas, the practicalities of funding and setting up surveillance 
systems with limited infrastructure and capacity of health profes-
sionals at all government levels can be a barrier for implementa-
tion. Hence, existing platforms, such as the intergrated Health 
and Demography Surveillance System (iHDSS), are believed to 
have considerable potential for use as surveillance systems.
Conclusion
This review showed significant variations in the prevalence 
of NCD and the risk factors across PNG. It also showed that 
the increased prevalence of NCD risk factors was mainly 
from peri-urban and urban areas, as well as among geneti-
cally predisposed populations, such as the Austronesian lan-
guage–speaking group of people.
The review identified a great paucity of data on NCDs 
and their risk factors over the years. There is a lack of updated 
prevalence data and/or consistency in data collection or sur-
veillance of NCD and their risk factors in most areas across 
PNG. Thus, countrywide surveillance of NCD and major 
risk factors should be a priority for the country to enable 
appropriate monitoring of such diseases to guide appropriate 
public health interventions. By establishing the prevalence 
of NCDs and their risk factors, the country can implement 
strategies to reduce and control the growing NCD disease 
burden.
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